Skip to main content
Screener/Healthcare/Biotechnology

MDGL — Madrigal Pharmaceuticals, Inc.

NASDAQ
$395.70-5.23 (-1.31%)
Mid CapHealthcareFastest Growing
$353.54
$615.00
$378.27
$401.61
EPS (TTM)$-12.80
P/E Ratio-40.21
Dividend Yield—
Market Cap$9.94B
Volume940K
Prev Close$400.10
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$311.3M-$94.4M$-3.2591.4%-30.3%
Q4 '25$321.1M-$58.6M$-2.5792.4%-18.2%
Q3 '25$287.3M-$114.2M$-5.0893.7%-39.8%
Q2 '25$212.8M-$42.3M$-1.9095.7%-19.9%
Q1 '25$137.3M-$73.2M$-3.3296.7%-53.4%
Q4 '24$103.3M-$59.4M$-2.7196.7%-57.5%
Q3 '24$62.2M-$107.0M$-4.9296.5%-172.0%
Q2 '24$14.6M-$152.0M$-7.1095.7%-1038.2%
Get Your Daily Market Recap